Phio Pharmaceuticals receives patent approvals in U.S., Canada, and Japan

Go back to Phio Pharmaceuticals receives patent approvals in U.S., Canada, and Japan
(NASDAQ: PHIO) Delayed: 1.03 -0.05 (4.63%)
Previous Close $1.08    52 Week High
Open $1.07    52 Week Low
Day High $1.08    P/E N/A 
Day Low $1.02    EPS
Volume 320,410